{
  "ticker": "REGN",
  "company": "Regeneron Pharmaceuticals",
  "quarter": "Q3 2025",
  "date": "2025-07-28",
  "content": "Regeneron Pharmaceuticals Financial Overview\nData as of: 2025-07-28\n\nCompany Metrics:\nStock Price: $14.25\nMarket Cap: $66,527,051,039\n52-Week High: $18.52\n52-Week Low: $9.97\n\nValuation Metrics:\nP/E Ratio (TTM): 41.9\nForward P/E: 37.7\nPEG Ratio: 2.92\nPrice to Book: 4.1\n\nFinancial Performance:\nRevenue (TTM): $2,848,084,952\nRevenue Growth (YoY): 43.7%\nGross Margin: 74.5%\nOperating Margin: 29.6%\nNet Margin: 18.9%\n\nProfitability:\nReturn on Assets: 26.8%\nReturn on Equity: 32.6%\nProfit Margin: 18.9%\n\nTrading Information:\nBeta: 1.92\nDividend Yield: 1.62%\nPrevious Close: $13.96\nDay Range: $13.82 - $14.53\nVolume: 26,152,667\nAverage Volume: 6,723,847",
  "source": "batch-cache",
  "cached_at": "2025-07-28T21:15:02.692687"
}